13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 32 holding rows worth $830,929,000.
- Accession
- 0001085146-21-002505
- Filer
- CIK 1544773
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 32 entries on the cover page, a total value of $830,929,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $830,929,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 3,446,874 | $154,696,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 1,199,339 | $98,838,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 979,226 | $95,377,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 1,084,979 | $84,118,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,647,497 | $67,630,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 13,600,014 | $55,352,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 887,885 | $37,708,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 409,301 | $31,819,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 159,087 | $28,542,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 3,176,418 | $27,000,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 2,858,558 | $18,323,000 | thousands by filing date | |
| CASI PHARMACEUTICALS INC | 14757U109 | COM | 10,321,956 | $15,999,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 12,744,030 | $14,656,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 388,222 | $14,213,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 439,876 | $13,940,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 3,766,817 | $11,263,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 1,025,405 | $10,551,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 1,000,000 | $10,391,000 | thousands by filing date | |
| SIO GENE THERAPIES INC | 829399104 | COM | 2,969,987 | $8,108,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 222,222 | $5,779,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F500 | COM PAR | 3,913,000 | $4,656,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 300,000 | $3,032,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 300,000 | $2,982,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 300,000 | $2,895,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 213,036 | $2,748,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 250,000 | $2,680,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 180,000 | $2,048,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP II | G6882C106 | COM | 200,000 | $2,002,000 | thousands by filing date | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 75,000 | $1,780,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 150,000 | $1,552,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 45,960 | $217,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 33,331 | $34,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-21-002505 | this filing | 2021-08-16 | acceptance time not in the bulk data set |